Extracellular polysaccharide from Bordetella species reduces high glucose-induced macrophage apoptosis via regulating

Min Li1, Fei Lin2, Yanliang Lin3

  • 1Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China.

Insights

Extracellular polysaccharide (EPS) from Bordetella species protects macrophages from high glucose-induced apoptosis during hypoxia. This involves TLR4-dependent caveolin-1 phosphorylation, enhancing glucose uptake and promoting macrophage survival in diabetic atherosclerosis.

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Immunology

Background:

  • Macrophage apoptosis is a key factor in atherosclerotic lesions, particularly in diabetic patients.
  • High glucose levels in diabetes promote macrophage apoptosis by inhibiting Akt phosphorylation and activating caspase 3.

Purpose of the Study:

  • To investigate the protective effects of extracellular polysaccharide (EPS) from Bordetella species on macrophages under high glucose and hypoxic conditions.
  • To elucidate the molecular mechanisms underlying EPS-mediated protection.

Main Methods:

  • Primary peritoneal macrophages were treated with high glucose and subjected to hypoxia.
  • The effects of EPS on cell apoptosis, Akt phosphorylation, caspase 3 activation, caveolin-1 phosphorylation, and Glut1 levels were assessed.
  • Toll-like receptor 4 (TLR4) involvement was investigated.

Main Results:

  • High glucose induced macrophage apoptosis, while hypoxia prolonged survival.
  • EPS treatment significantly reduced apoptosis in high glucose and hypoxic conditions.
  • EPS promoted TLR4-dependent caveolin-1 phosphorylation, increasing membrane Glut1 levels and glucose consumption.
  • EPS facilitated the association of caveolin-1 with TLR4, activating the TLR4 signaling pathway.

Conclusions:

  • Extracellular polysaccharide (EPS) from Bordetella species confers a protective effect on macrophages against high glucose-induced apoptosis under hypoxic conditions.
  • The protective mechanism involves the TLR4-caveolin-1 signaling pathway, leading to enhanced glucose uptake and reduced apoptosis, offering a potential therapeutic strategy for diabetic atherosclerosis.